• Reactive Astrocyte–Microglia Crosstalk in 1,2-DCE

  2026-09-21

  The reference study identifies reactive astrocytes as an early cellular driver of 2-chloroethanol-associated neuroinflammation, linking ROS-dependent p38 MAPK, NF-κB, and AP-1 signaling to A1 astrocyte activation and subsequent M1 microglial polarization. Its cell-based design provides a useful framework for separating direct chemical effects on microglia from cytokine-mediated astrocyte–microglia communication in toxic encephalopathy research.

• Azithromycin and Roxithromycin as Senolytics

  2026-09-20

  The reference study established a streamlined human fibroblast model for screening clinically approved drugs against senescent cells and identified azithromycin and roxithromycin as selective senolytic candidates. Its combination of viability, metabolic, autophagy, and real-time impedance measurements provides a useful framework for interpreting drug-induced senescent cell clearance while highlighting the need for orthogonal senescence validation.

• HyperScribe™ for Translational mRNA Design

  2026-09-19

  Explore how HyperScribe™ All in One mRNA Synthesis Kit II supports cap-, T7-, and poly(A)-focused mRNA workflows. This article translates findings from an LNP-mRNA fibroblast study into practical design, quality-control, and assay decisions for inflammatory disease research.

• Oteseconazole (VT-1161) Candida Workflows

  2026-09-18

  Build more reliable Candida susceptibility, resistance, and selectivity assays with Oteseconazole (VT-1161), a selective tetrazole CYP51 inhibitor. This practical workflow separates product-backed performance from assay starting points and shows how to troubleshoot solubility, controls, endpoint variation, and species-specific results.

• Light-Inducible RNA Release for Regulated Gene Therapy

  2026-09-18

  The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage. In mouse models, LIRP-regulated AAV systems enabled light-dependent treatment of diet-induced obesity and reversible control of VEGF inhibition in retinal disease, illustrating a potential safety advantage for on-demand gene therapy.

• Schisandrin B Mitigates Nickel Nanoparticle Lung Injury

  2026-09-17

  The reference study identifies a Sirt3-associated mitochondrial redox and lipid-metabolism axis in human lung epithelial injury caused by nickel nanoparticles. By combining computational toxicology with Sirt3 gain- and loss-of-function experiments, it shows that Schisandrin B is associated with improved mitochondrial function, lipid handling, inflammatory signaling, and apoptosis-related outcomes.

• QRICH1 Links ER Stress to HBV-Driven HMGB1 Secretion

  2026-09-17

  A 2025 Immunobiology study identifies QRICH1 as an important effector connecting endoplasmic reticulum stress with HMGB1 transcription, acetylation, translocation, and secretion during HBV-associated hepatic fibrosis. By combining a chronic rcccDNA mouse model, human liver specimens, histology, immunoassays, and molecular analyses, the work provides a mechanistic framework for interpreting inflammatory liver injury and for designing follow-up studies.

• Single-Molecule Imaging of R-Loop Collisions

  2026-09-16

  The reference study uses DNA-curtain single-molecule fluorescence imaging to show how individual R-loops interfere with Phi29 DNA polymerase progression. Its results identify strand orientation, exposed-DNA secondary structure, G-quadruplex formation, and transcription-complex occupancy as important determinants of replication stalling.

• Bismuth Subsalicylate: GI Assay Workflows

  2026-09-16

  Build more reproducible gastrointestinal disorder research workflows with Bismuth Subsalicylate while accounting for its water-, ethanol-, and DMSO-insoluble nature. This guide combines inflammation pathway modulation with annexin V membrane readouts to distinguish pathway effects from precipitation, cytotoxicity, and assay artifacts.

• CX-5461 RNA Polymerase I Inhibitor Workflows

  2026-09-15

  CX-5461 enables focused studies of Pol I-driven rRNA synthesis, nucleolar stress, DNA damage, autophagy, and senescence in cancer models. This practical guide connects formulation, dose-response design, cervical cancer findings, and cisplatin-combination assays to reproducible research workflows.

• Surfactant-Derived LNPs Deliver mRNA to Macrophages

  2026-09-15

  Huang and colleagues developed a dual-component lipid nanoparticle system that uses a surfactant-derived lipid and a fusogenic lipid to deliver mRNA into difficult-to-transfect macrophages. Their findings show that quaternary ammonium compound structure and formulation design can produce nuclease-resistant, biocompatible carriers without a PEGylated lipid, providing a useful framework for macrophage engineering.

• Temafloxacin Pharmacokinetics: 1991 Review

  2026-09-14

  Dudley’s review integrated human pharmacokinetic data for temafloxacin with pharmacodynamic considerations to explain its high oral bioavailability, prolonged elimination, tissue distribution, and dosing implications. The findings support once- or twice-daily administration while identifying renal function as the principal factor requiring interval adjustment.

• EGCG Nanoparticles Enhance FLASH-RT Antitumor Activity

  2026-09-14

  Xu and colleagues developed functionalized, self-assembled EGCG nanoparticles named BENPs to address the limited tumor control observed with FLASH-RT. In a breast tumor model, BENPs increased radiation-associated oxidative and DNA damage, promoted tumor-cell death, and reshaped systemic immune responses without an evident increase in measured toxicity.

• Sulfo-NHS-SS-Biotin for Cell-Surface Workflows

  2026-09-13

  Sulfo-NHS-SS-Biotin combines aqueous compatibility, amine-selective labeling, and a reducible disulfide linker for reversible cell-surface protein capture. This article translates recent glycoRNA–RNA-binding protein findings into practical labeling, enrichment, western blotting, and interactome workflows.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-12

  Brumatti, Sheridan, and Martin describe a practical bacterial-expression strategy for producing soluble, polyhistidine-tagged recombinant annexin V and converting it into a fluorescent probe for phosphatidylserine detection. The workflow connects scalable protein production with flow-cytometric and fluorescence-microscopy assays, while also clarifying why phosphatidylserine exposure is useful but not entirely specific for apoptosis.

8068 records 1/538 page Next 12345 下5页 Last page